845 results on '"Costs and Cost Analysis"'
Search Results
2. Remote Hypertension Monitoring Improved Medication Use, Raised Costs.
3. Survey: Millions of People in the US Forgo Medications to Reduce Costs.
4. Pricing of Drugs With Evidence Development-Reply
5. Nondrug Interventions for Dementia Improved Life, Reduced Costs.
6. Availability, Cost, and Consumer Ratings of Popular Nonvalidated vs Validated Blood Pressure-Measuring Devices Sold Online in 10 Countries.
7. Trends in Reported Health Care Affordability for Men and Women With Employer-Sponsored Health Insurance Coverage in the US, 2000 to 2020
8. Accuracy of Electronic Health Record Food Insecurity, Housing Instability, and Financial Strain Screening in Adult Primary Care.
9. Risks to the 340B Drug Pricing Program
10. Risks to the 340B Drug Pricing Program—Reply
11. New Reforms to Prescription Drug Pricing in the US
12. Adherence to a Federal Hospital Price Transparency Rule and Associated Financial and Marketplace Factors
13. Long-Acting Cabotegravir for HIV Prevention
14. Risks to the 340B Drug Pricing Program.
15. Risks to the 340B Drug Pricing Program-Reply.
16. Pricing of Drugs With Evidence Development-Reply.
17. Pricing of Drugs With Evidence Development.
18. Is Affording Undocumented Immigrants Health Coverage a Radical Proposal?
19. The Growing Problem of Out-of-Pocket Costs and Affordability in Employer-Sponsored Insurance
20. Expiration of Pandemic-Related Marketplace Insurance Policies: Implications for Affordability and Coverage.
21. Adherence to a Federal Hospital Price Transparency Rule and Associated Financial and Marketplace Factors.
22. Drug Pricing With Evidence Development.
23. Defining Value-Based Pricing of Drugs
24. Defining Value-Based Pricing of Drugs-Reply
25. Long-Acting Cabotegravir for HIV Prevention: Issues of Access, Cost, and Equity.
26. Prevalence, Characteristics, and Costs of Urgent Care Center Membership Programs
27. Rising Prices and Health Care 'Empires'
28. Wasteful Health Care Spending in the United States
29. Toward Evidence-Based Policy Making to Reduce Wasteful Health Care Spending
30. Trends in Differences in Health Status and Health Care Access and Affordability by Race and Ethnicity in the United States, 1999-2018.
31. The Growing Problem of Out-of-Pocket Costs and Affordability in Employer-Sponsored Insurance.
32. Value-Based Pricing and State Reform of Prescription Drug Costs
33. Factors Influencing Prescription Drug Costs in the United States-Reply
34. Cost of Antihyperglycemic Medications in the United States--Reply
35. Vaccine Pricing and US Immunization Policies--Reply
36. Prevalence and Cost of Office Visits Prior to Colonoscopy for Colon Cancer Screening
37. At What Cost?: Medical Education 2016
38. Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System
39. Costs of Quality Measurement
40. Costs of Quality Measurement—Reply
41. Prevalence, Characteristics, and Costs of Urgent Care Center Membership Programs.
42. Research and Development Costs of New Drugs-Reply.
43. Research and Development Costs of New Drugs.
44. Research and Development Costs of New Drugs.
45. Research and Development Costs of New Drugs.
46. Rising Prices and Health Care "Empires".
47. Wasteful Health Care Spending in the United States.
48. Drug Shortages in the United States: Are Some Prices Too Low?
49. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
50. Wasteful Health Care Spending in the United States.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.